Research

It is clear that the ways in which SARS-CoV-2 interacts with our immune system are complex and have huge implications for disease outcome. Learning more about the immunology of the virus can help us fight COVID-19 and develop better diagnostics, treatments and vaccines. 

The consortium's research is divided into five key areas, each of which tackle different aspects of the virus' immunological features. These themes are:

  1. Primary immunity: Why are some people's immune systems better able to fight off the virus?

  2. Protective immunity: What parts of the immune system are involved in generating a protective response against COVID-19 and how long does this immunity last?

  3. Immunopathology: How does the immune system respond to SARS-CoV-2 on a molecular and cellular level and what happens when the immune system overreacts?

  4. Cross-reactive coronavirus immunity: Does immunity to previous infection with seasonal coronaviruses (which cause the common cold) alter a person's outcome with SARS-CoV-2?

  5. Immune evasion: How does SARS-CoV-2 'hide from' the immune system and how can this be tackled?

 

Read more about each of the research themes below:

Primary immunity: Why are some people's immune systems better able to fight off the virus?

Theme 1 is led by Professor Tracy Hussell, Professor of Inflammatory Disease at the University of Manchester

Read more

Protective immunity: What parts of the immune system are involved in generating a protective response against COVID-19 and how long does this immunity last?

Theme 2 is led by Professor Paul Klenerman, Sidney Truelove Professor of Gastroenterology at the University of Oxford

Read more

Cross-reactive coronavirus immunity: Does immunity to previous infection with seasonal coronaviruses alter a person's outcome with SARS-CoV-2?

Theme 4 is led by Professor Mala Maini, Professor of Viral Immunology at University College London

Read more

Immune evasion: How does SARS-CoV-2 'hide from' the immune system and how can this be tackled?

Theme 5 is led by Professor Paul Lehner, Professor of Immunology and Medicine at the University of Cambridge

Read more